摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

H2LDL‑phe | 1164117-92-3

中文名称
——
中文别名
——
英文名称
H2LDL‑phe
英文别名
N-[(imidazol-4-yl)methylidene]-DL-phenylalanine;H2LDL-phe
H2LDL‑phe化学式
CAS
1164117-92-3
化学式
C13H13N3O2
mdl
——
分子量
243.265
InChiKey
DFVLMUZHJRFHDI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.52
  • 重原子数:
    18.0
  • 可旋转键数:
    5.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    78.34
  • 氢给体数:
    2.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    copper(II) choride dihydrate 、 H2LDL‑phe甲醇 为溶剂, 生成
    参考文献:
    名称:
    铜 (II) 和锌 (II) 配合物与咪唑-4-甲醛衍生物和 DL-苯丙氨酸的 1:1 缩合产物的对映选择性组装结构
    摘要:
    铜 (II) 与三齿配体 H2LR(R = H、2-Me 和 5-Me)的配合物源自 DL-苯丙氨酸和咪唑-4-甲醛衍生物(咪唑-4-甲醛)的 1:1 缩合产物...
    DOI:
    10.1246/bcsj.82.458
  • 作为产物:
    描述:
    DL-苯丙氨酸4-咪唑甲醛甲醇 为溶剂, 反应 0.5h, 生成 H2LDL‑phe
    参考文献:
    名称:
    铜 (II) 和锌 (II) 配合物与咪唑-4-甲醛衍生物和 DL-苯丙氨酸的 1:1 缩合产物的对映选择性组装结构
    摘要:
    铜 (II) 与三齿配体 H2LR(R = H、2-Me 和 5-Me)的配合物源自 DL-苯丙氨酸和咪唑-4-甲醛衍生物(咪唑-4-甲醛)的 1:1 缩合产物...
    DOI:
    10.1246/bcsj.82.458
点击查看最新优质反应信息

文献信息

  • Synthesis, Structure, Luminescence, and Magnetic Properties of a Single-Ion Magnet “<i>mer</i>”-[Tris(<i>N</i>-[(imidazol-4-yl)-methylidene]-<scp>dl</scp>-phenylalaninato)terbium(III) and Related “<i>fac</i>”-<scp>dl</scp>-Alaninato Derivative
    作者:Suguru Yamauchi、Takeshi Fujinami、Naohide Matsumoto、Naotaka Mochida、Takayuki Ishida、Yukinari Sunatsuki、Masayuki Watanabe、Masanobu Tsuchimoto、Cecilia Coletti、Nazzareno Re
    DOI:10.1021/ic5001599
    日期:2014.6.16
    and easy-axis (Ising type) magnetic anisotropies for 1 and 2, respectively. Highly efficient luminescences with Φ = 0.50 and 0.61 for 1 and 2, respectively, were observed, and the luminescence fine structure due to the 5D4 → 7F6 transition is in good accordance with the energy diagram determined from magnetic analysis. The energy diagram of 1 shows an approximate single-well potential curve, whereas that
    两个具有相同N 6 O 3供体原子但配位几何结构不同的Tb III络合物,“ fac ”-[Tb III(HL dl -ala)3 ]·7H 2 O(1)和“ mer ”-[Tb III(HL)合成了dl -phe)3 ]·7H 2 O(2),其中H 2 L dl -ala和H 2 L dl -phe是N -[(咪唑-4-基)亚甲基] -dl-丙酸和-d1-苯丙酸。每个Tb III离子均由三个电子单负NNO三齿配体配位,以形成三重三角棱镜的配位几何形状。化合物1由对映异构体“ fac ”-[Tb III(HL d -ala)3 ]和“ fac ”-[Tb III(HL 1- al)3 ]组成,而化合物2由“ mer ”-[Tb III(HL d)(HL )组成d -phe)2(HL l- phe)]和“mer ”-[Tb III(HL d -phe)(HL l -phe)2 ]。通过自旋哈密顿量分析了磁数据,包括对Tb
  • ‘Facial’ and ‘meridional’ coordination geometries and luminescence properties of tris(N-[(imidazol-4-yl)methylidene]-dl-alaninato)europium(III) and tris(N-[(imidazol-4-yl)methylidene]-dl-phenylalaninato)europium(III)
    作者:Suguru Yamauchi、Tomotaka Hashibe、Mami Murase、Hiroaki Hagiwara、Naohide Matsumoto、Masanobu Tsuchimoto
    DOI:10.1016/j.poly.2012.10.003
    日期:2013.1
    Two racemic tridentate ligands, N-[(imidazol-4-yl)methylidene]-DL-alanine (H2LDL-ala) and N-[(imidazol-4-yl)methylidene]-DL-phenylalanine (H2LDL-phe), were synthesized by the 1:1 condensation reaction of 4-formylimidazole and either of DL-alanine and DL-phenylalanine, respectively. The Eu-III complexes 'fac'-[Eu-III(HLDL-ala)(3)]center dot 8H(2)O (1) and 'mer'-[Eu-III(HLDL-phe)(3)]center dot 7.75H(2)O (2) were synthesized by mixing the ligand and Eu-III(acetate)(3) n-hydrate with 3:1 M ratio in methanol and the crystal structures were determined. Compounds 1 and 2 with three tridentate ligands have 'facial' and 'meridional' geometries, respectively, while they have a tricapped trigonal prismatic (TTP) and a capped square antiprismatic (CSAP) coordination geometry, respectively. In the crystal lattice, 1 consists of enantiomers 'fac'-[Eu-III(HLD-ala)(3)] and 'fac'-[Eu-III(HLL-ala)(3)], while 2 consists of 'mer'-[Eu-III(HLD-phe)(2)(HLL-phe)] and 'mer'-[Eu-III(HLD-phe)(HLL-phe)(2)]. Compounds 1 and 2 displayed sharp emission bands based on the f-f transitions by excitation and showed a different emission pattern due to their 'fac'- and 'mer'-coordination geometries. The luminescence quantum yields and life times of 1 and 2 were estimated to be (Phi = 0.25 and 1.40 ms) and (Phi = 0.30 and 1.23 ms), respectively. (c) 2012 Elsevier Ltd. All rights reserved.
  • Luminescent DyIII single ion magnets with same N6O3 donor atoms but different donor atom arrangements, ‘fac’-[DyIII(HLDL-ala)3]·8H2O and ‘mer’-[DyIII(HLDL-phe)3]·7H2O
    作者:Daisuke Hamada、Takeshi Fujinami、Suguru Yamauchi、Naohide Matsumoto、Naotaka Mochida、Takayuki Ishida、Yukinari Sunatsuki、Masanobu Tsuchimoto、Cecilia Coletti、Nazzareno Re
    DOI:10.1016/j.poly.2016.01.048
    日期:2016.4
    Two Dym complexes with same N603 donor atoms but different donor atom arrangements 'fac'-[Dy-III(HLDL-ala)(3)]center dot 8H(2)O (1) and 'mer'-[Dy-III(HLDL-phe)(3)]center dot 7H(2)O (2) were synthesized, where H2LDL-ala and H2LDL-phe are tridentate NNO ligands of N-Rimidazol-4-yl)methylidene]-DL-alanine and N-[(imidazol-4-yl)methylidene]-DL-phenylalanine, respectively. Each Dy-III ion is coordinated by three mono-deprotonated mono-negative NNO tridentate ligands to form a nona-coordination geometry of a tricapped trigonal prism (TTP). 1 consists of enantiomers 'fac'-[Dy-III(HLD-ala)(3)], and 'fac'-[Dy-III(HLL-ala)(3)], while 2 consists of 'mer'-[Dy-III(HLD-phe)(2)(HLL-phe)] and 'mer'-[Dy-III(HLD-phe)(HLL-ala)(2)]. The temperature dependence of the magnetic susceptibilities and field-dependence of the magnetization of two complexes showed the different magnetic profiles and the Stark splitting of the ground state H-6(15/2) due to the crystal field effect on Dy-III ion (4f(9), J = 15/2, S = 5/2, L = 5, g(J) = 4/3, H-6(15/2)). Luminescence spectra were observed and the fine structures assigned to the F-4(9/2) -> H-6(15/2) transitions are partially observed. 1 and 2 showed an out-of phase signal with frequency-dependence in alternating current (ac) susceptibility under a dc bias field of 1000 Oe, indicative of field induced single ion magnet (SIM). The ac magnetic susceptibilities under 1000 Oe dc field of 2 showed the maximum peaks at the higher temperature than those of 1, indicating that the energy barrier of 2 is larger than that of 1. (C) 2016 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸